Skip to content

Tag Archives: Amgen Inc

Overnight Market News – January 26, 2010

26-Jan-10

UK Exits Recession with Fourth-Quarter Economic Growth of 0.1% Year-Over-Year, But Falls Short of Analysts’ Forecast for 0.4% Expansion Apple Inc Posts Fiscal First-Quarter Profit of USD 3.67 per Share, Crushing Analysts’ Estimates of USD 3.50 per Share on Record Sales of iPhones and Mac Computers US President Obama to Propose Three-Year Freeze on a [...]

FDA Delays Approval Of Bone Loss Treatment Drug Prolia

23-Oct-09

After Amgen Inc. posted earnings that beat expectations, the U.S. Food & Drug Administration (FDA) quickly put a stop to the celebration, delaying the approval of its next potential best-seller – Prolia. The FDA requested that further testing be conducted on the drug Prolia, before it could approve the drug for treating bone loss. It [...]